Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Core Laboratories's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 83.02.
Core Laboratories's Days Inventory for the
three
months ended in Mar. 2026 was 48.37.
Core Laboratories's Days Payable for the
three
months ended in Mar. 2026 was 33.28.
Therefore, Core Laboratories's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 98.11.
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Core Laboratories Cash Conversion Cycle Related Terms
Core Laboratories Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Core Laboratories's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:CLB vs EROK, OIS, NGS: Cash Conversion Cycle Comparison
For the Oil & Gas Equipment & Services subindustry, Core Laboratories's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Core Laboratories Cash Conversion Cycle vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, Core Laboratories's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Core Laboratories's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Core Laboratories's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Core Laboratories (MEX:CLB) has a Cash Conversion Cycle of 98.11 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Core Laboratories and its competitors.
Is Core Laboratories' Cash Conversion Cycle too high?
Core Laboratories' current Cash Conversion Cycle is 98.11. The Oil & Gas industry median Cash Conversion Cycle is 18.22. Core Laboratories' value of 98.11 is 438.5% above this industry median. Overall, Core Laboratories has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' Cash Conversion Cycle compare to EROK and OIS?
Core Laboratories' Cash Conversion Cycle of 98.11 can be compared against companies in the Oil & Gas industry. The industry median Cash Conversion Cycle is 18.22. Core Laboratories' value of 98.11 is 438.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for an Oil & Gas company?
The median Cash Conversion Cycle among Oil & Gas companies is 18.22, based on 915 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Core Laboratories's current Cash Conversion Cycle of 98.11 is 438.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Core Laboratories and its competitors. For the Oil & Gas industry, the median Cash Conversion Cycle is 18.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Core Laboratories's current Cash Conversion Cycle is 98.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Core Laboratories (MEX:CLB) has a current Cash Conversion Cycle of 98.11. The stock's GF Value™ is MXN1,344.78, compared to a current price of MXN856.38 — trading 36.3% below its estimated fair value. The current Cash Conversion Cycle is 98.11 and 438.5% above the Oil & Gas industry median of 18.22. Core Laboratories' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Core Laboratories (MEX:CLB), the current Cash Conversion Cycle is 98.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Core Laboratories (MEX:CLB) Overvalued in 2026?
Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued.
The current stock price of MXN856.38 is trading 36.3% below its estimated GF Value™ of MXN1,344.78.
Key valuation signals for MEX:CLB:
Cash Conversion Cycle: 98.11
GF Value™: MXN1,344.78 vs. price of MXN856.38 (36.3% below fair value)
Industry Position: 438.5% above the Oil & Gas median
No single metric tells the full story. See the MEX:CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
62GF Score
Get the complete analysis for MEX:CLB
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CLB has been successfully added to your 
